AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and announcing a change at the top.
StockWatch: Recursion Slides on Data Update as New CEO Named
- Advertisement -
APLICATIONS
Why luxury watchmakers think the timing is right to go smaller
Discover the allure of smaller dials, from Bulgari’s Serpenti to Omega’s Aqua Terra, blending elegance with high horology precision.
